Literature DB >> 28237413

Impact of Retinitis Pigmentosa on Quality of Life, Mental Health, and Employment Among Young Adults.

Anne Elisabeth Chaumet-Riffaud1, Philippe Chaumet-Riffaud2, Anaelle Cariou3, Céline Devisme3, Isabelle Audo4, José-Alain Sahel5, Saddek Mohand-Said4.   

Abstract

PURPOSE: To determine the relationship between visual function and quality of life, education, mental health, and employment among young adults with retinitis pigmentosa (RP).
DESIGN: Cross-sectional study.
METHODS: Inclusion of 148 patients (mean age 38.2 ± 7.1 years) diagnosed with RP, living in France. Quality of life was assessed using the National Eye Institute Visual Function Questionnaire (VFQ-25), mental state with the Hospital and Anxiety and Depression Scale (HADS), and employment with a specifically designed questionnaire.
RESULTS: Limited visual impairment was noted in 22.3%, low vision in 29.7%, and legal blindness in 48.0%. There was a correlation between quality-of-life scores and residual visual field (P < .0001). Mental health scores were suggestive of anxiety in 36.5% and depression in 15.5%. The rates did not increase with disability level (P = .738, P = .134). The percentage of subjects with higher education did not significantly decrease with disability level (P = .113). The employment rate did not significantly decrease with disability level (P = .276). It was lower in subjects reporting depression (P = .0414). Self-rated impact of RP on employment increased with disability level (P = .02642).
CONCLUSIONS: Our results differ from previous results showing lower education rates and employment rates in young adults with RP. Further research is warranted focusing on the impact of mental health, education, workplace conditions, and employment aids on employment rate vs age- and education-matched normally sighted controls to guide visual disability strategies in RP.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28237413     DOI: 10.1016/j.ajo.2017.02.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Julie M Rosenthal; Joshua R Ehrlich; David C Musch; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-06-22       Impact factor: 1.803

2.  Artificial vision: the effectiveness of the OrCam in patients with advanced inherited retinal dystrophies.

Authors:  Xuan-Thanh-An Nguyen; Jan Koopman; Maria M van Genderen; Henk L M Stam; Camiel J F Boon
Journal:  Acta Ophthalmol       Date:  2021-09-26       Impact factor: 3.988

Review 3.  NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies.

Authors:  Jonathan B Lin; Rajendra S Apte
Journal:  Prog Retin Eye Res       Date:  2018-06-12       Impact factor: 21.198

4.  The Michigan Vision-Related Anxiety Questionnaire: A Psychosocial Outcomes Measure for Inherited Retinal Degenerations.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; Chris A Andrews; Rebhi Abuzaitoun; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Natasha Baig; Joshua R Ehrlich; Abigail T Fahim; Kari H Branham; Bonnielin K Swenor; Paul R Lichter; Gislin Dagnelie; Joan A Stelmack; David C Musch; K Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2020-12-09       Impact factor: 5.258

5.  Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.

Authors:  Jacque L Duncan; Wendi Liang; Maureen G Maguire; Isabelle Audo; Allison R Ayala; David G Birch; Joseph Carroll; Janet K Cheetham; Simona Degli Esposti; Todd A Durham; Laura Erker; Sina Farsiu; Frederick L Ferris; Elise Heon; Robert B Hufnagel; Alessandro Iannaccone; Glenn J Jaffe; Christine N Kay; Michel Michaelides; Mark E Pennesi; José-Alain Sahel
Journal:  Am J Ophthalmol       Date:  2020-05-22       Impact factor: 5.488

6.  Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa.

Authors:  Mayumi Sainohira; Takehiro Yamashita; Hiroto Terasaki; Shozo Sonoda; Kazunori Miyata; Yusuke Murakami; Yasuhiro Ikeda; Takeshi Morimoto; Takao Endo; Takashi Fujikado; Junko Kamo; Taiji Sakamoto
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

7.  Validation of a vision-related activity scale for patients with retinitis pigmentosa.

Authors:  Francisco M Costela; Konrad Pesudovs; Michael A Sandberg; Carol Weigel-DiFranco; Russell L Woods
Journal:  Health Qual Life Outcomes       Date:  2020-06-22       Impact factor: 3.186

Review 8.  Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases.

Authors:  Emmanuelle Clérin; Myriam Marussig; José-Alain Sahel; Thierry Léveillard
Journal:  Int J Mol Sci       Date:  2020-02-27       Impact factor: 5.923

Review 9.  Outcome measures in juvenile X-linked retinoschisis: A systematic review.

Authors:  John R Grigg; Claire Y Hooper; Clare L Fraser; Elisa E Cornish; Peter J McCluskey; Robyn V Jamieson
Journal:  Eye (Lond)       Date:  2020-04-20       Impact factor: 3.775

10.  A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice.

Authors:  Renee C Ryals; Samuel J Huang; Dahlia Wafai; Claire Bernert; William Steele; Makayla Six; Shasank Bonthala; Hope Titus; Paul Yang; Melanie Gillingham; Mark E Pennesi
Journal:  Transl Vis Sci Technol       Date:  2020-10-14       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.